We have found that HRG increases phosphorylation of Ebp1 in breast cancer cells (Lessor et al, 2000) and studies are underway in the laboratory to examine if enhanced phosphorylation of Ebp1 increases its binding to AR. Here, AR is linked to breast carcinoma.